STUELPNAGEL JOHN R · 10x Genomics, Inc. · 3h agono track record yet
Sold 20,000 @ $57.75 avg · $1,155,055 · 2026-08-11
Form 4: STUELPNAGEL JOHN R sold TXG
STUELPNAGEL JOHN R (Director at 10x Genomics, Inc.) reported an open-market sale of 20,000 shares of TXG at an average $57.75, roughly $1,155,055, in a Form 4 filed 2026-08-13.
Now $45.82as of Jul 15, 2:55 PM ET